Rendering

Component: (Network and Table)
Network
100650 - Disclosure - Components of Net Deferred Taxes (Detail)
(http://www.abiomed.com/20160331/taxonomy/role/DisclosureComponentsOfNetDeferredTaxesDetail)
Table(Implied)
Slicers (applies to each fact value in each table cell)
Reporting Entity [Axis]0000815094 (http://www.sec.gov/CIK)
Income Tax Disclosure [Abstract]Period [Axis]
2016-03-31
2015-03-31
Income Tax Disclosure [Abstract]
 
 
Deferred tax assets
 
 
NOL carryforwards and tax credit carryforwards
34,305,000  
60,081,000  
Stock-based compensation
14,879,000  
10,568,000  
Nondeductible reserves and accruals
8,550,000  
7,573,000  
Amortizable intangibles other than goodwill
2,420,000  
2,993,000  
Capitalized research and development
442,000  
1,597,000  
Foreign NOL carryforwards
17,635,000  
19,617,000  
Deferred revenue
3,351,000  
2,669,000  
Depreciation
353,000  
276,000  
Other, net
1,802,000  
1,298,000  
Deferred Tax Assets, Gross, Total
83,737,000  
 
106,672,000  
 
Deferred tax liabilities
 
 
Indefinite lived intangibles
(8,480,000) 
(7,530,000) 
In-process research and development
(4,649,000) 
(4,443,000) 
Domestic deferred tax liability on foreign NOL carryforwards
(10,488,000) 
(12,276,000) 
Deferred Tax Liabilities, Net
(23,617,000) 
 
(24,249,000) 
 
Net deferred tax assets
60,120,000  
 
82,423,000  
 
Valuation allowance
(2,418,000) 
(2,912,000) 
Net deferred tax assets
57,702,000  
 
79,511,000  
 
Long-term deferred tax assets, net
58,534,000  
80,306,000  
Long-term deferred tax liabilities
(832,000) 
(795,000) 
Net deferred tax assets
57,702,000  
 
79,511,000